Denmark cuts AstraZeneca vaccine altogether

Published April 15, 2021
Director of Denmark's National Board of Health Soeren Brostroem addresses a press conference on April 14. — AFP
Director of Denmark's National Board of Health Soeren Brostroem addresses a press conference on April 14. — AFP

COPENHAGEN: Denmark on Wednesday announced it would stop using the AstraZeneca Covid-19 vaccine altogether, becoming the first European country to do so over suspected rare but serious side effects.

“Denmark’s vaccination campaign will go ahead without the AstraZeneca vaccine,” Danish Health Authority director Soren Brostrom told journalists, despite recommendations from the World Health Organisation and Europe’s medicines watchdog to keep using it.

“There is a potential cross-reaction between the vaccine and a low platelet count. We also know that there is a temporal connection. It occurs one week to ten days after the vaccination with AstraZeneca,” Brostrom said.

“The decision is contextual,” said Brostrom. “In Denmark, the majority of the population at risk has been vaccinated and the epidemic is under control.” Brostrom stressed that he shared the EMA’s assessment that the benefits of the vaccine outweigh the risks.

“I can well understand that other countries are using the vaccine,” he added.

Denmark’s health authority also said it “may re-introduce the vaccine at a later date if the situation changes”.

Denmark was the first country in Europe to suspend the use of AstraZeneca jab in its vaccination rollout, after reports of rare but serious cases of blood clots among those who had received the vaccine.

While more than a dozen countries followed suit, most have subsequently resumed its use after the European Medicines Agency (EMA), emphasised the benefits of the vaccine, judging it “safe and effective”.

Denmark however held off using the vaccine as it conducted investigations of its own, which concluded with Wednesday’s announcement that it was dropping its use — the first European country to do so.

It will instead continue its immunisation campaign using the Pfizer/BioNTech and Moderna vaccines.

South Africa in February excluded the vaccine in February over concerns about its effectiveness against the variant ravaging the country.

The United States, like Switzerland, has still not authorised the AstraZeneca drug, and Venezuela has refused to authorise it — citing its side effects.

In Denmark, two cases of thrombosis, one of them fatal, were linked to vaccinations after more than 140,000 people received the jab made by the Anglo-Swedish drugmaker.

According to a medical team at the National Hospital in Oslo in Norway, these atypical cases are due to “a powerful immune response” triggered by AstraZeneca’s vaccine.

In Denmark, a country of 5.8 million inhabitants, eight percent have been fully vaccinated against Covid-19 and 17 percent have received a first dose.

The suspension of the AstraZeneca jab will delay the country’s ambitious vaccine rollout plans, and those who have received a first dose of the AstraZeneca will be offered another vaccine.

The Nordic country also received the first doses of the Johnson & Johnson vaccine on Wednesday, but plans for a rollout have been halted pending a US investigation into the occurrence of blood clots.

The company immediately decided to delay the rollout of its single-dose vaccine in Europe, where it was the fourth vaccine to receive approval from the European Medicines Agency last month.

Denmark currently has a stockpile of some 200,000 doses of the AstraZeneca vaccine, which the health authority said will be kept in the “refrigerator” for the time being.

Published in Dawn, April 15th, 2021

Opinion

Pak-Saudi relations
Updated 17 May 2021

Pak-Saudi relations

Gulf states, led by Saudi Arabia, will be key to Pakistan’s economic recovery in a post-Covid context.
Cuisine and culture
17 May 2021

Cuisine and culture

There is a drive towards the creation of a ‘national cuisine’ landscape as well as greater insight into region-based diversity.
Cooperation or conflict?
Updated 17 May 2021

Cooperation or conflict?

The fear of an economic and technological rival has created insecurities being reflected today in US behaviour.

Editorial

Palestine bloodbath
Updated 17 May 2021

Palestine bloodbath

One wonders whether the right of self-defence allows a country to butcher toddlers and the disabled, as Tel Aviv has done in Gaza.
17 May 2021

Registering madressahs

DURING the past two decades, several attempts by successive governments to standardise and regularise madressahs ...
17 May 2021

LSM growth

THE robust growth in large-scale industrial output since July last year has generated a kind of economic optimism...
16 May 2021

Riyadh-Tehran thaw

SEVERAL official pronouncements over the last few days have confirmed that efforts are underway behind the scenes to...
16 May 2021

Ruthless evictions

FOR a state to deprive residents of their homes without providing for alternative housing for them is a dereliction...
16 May 2021

Wheat concerns

THE new official projections for provisional wheat output suggest that Punjab may harvest around 20.5m tonnes of...